Literature DB >> 21534641

Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes.

Scott Martin Vouri1, Robert F Shaw, Nancee V Waterbury, Jason A Egge, Bruce Alexander.   

Abstract

BACKGROUND: The "ABCs of Diabetes" are defined as hemoglobin A1c < 7.0%, blood pressure < 130/80 millimeters mercury (mm Hg), and lowdensity lipoprotein cholesterol (LDL-C) < 100 milligrams per deciliter (mg per dL). Assessments of 3-part goal attainment of A1c, blood pressure, and cholesterol have been reported using data from the National Health and Nutrition Examination Survey (NHANES) for several time periods (e.g., 1988-1994, 1999-2000, 1999-2002, and 2003-2004), Look Action for Health in Diabetes (Look AHEAD, 2001-2004), and community-based endocrinology practice (CBEP, 2000-2004). In 2002, an unpublished analysis of data from 2001-2002 at the Iowa City Veterans Affairs (ICVA) Medical Center found less than 50% of patients met each of the 3 individual goals. In the 5 years following the 2001-2002 assessment, the care for veterans with diabetes at the ICVA was enhanced to include (a) an increased number of diabetes classes and clinics, (b) implementation of the diabetes Care Coordination/Home Telehealth (CCHT) program, and (c) clinical reminders for diabetes performance measures that were added to the electronic medical record (EMR).
OBJECTIVES: To (a) describe the prevalence of veterans meeting the ABC goals of diabetes in 1 VA medical center; (b) differentiate the proportion of diabetes patients who met the individual targets for A1c, blood pressure, and LDL-C and compare the results for 2008 through September 2009 with the earlier data from this facility (2001-2002); and (c) examine results reported previously in the literature for NHANES, Look AHEAD, and CBEP data sources.
METHODS: Single-center, retrospective analysis of veterans at the ICVA for dates of service from January 1, 2008, through September 30, 2009, who (a) filled at least 1 prescription for an antidiabetic medication and (b) had each of the 3 biomarker values recorded in the EMR for A1c, blood pressure, and LDL-C after the antidiabetic prescription fill date.
RESULTS: Of the 5,426 (97.6% male) patients meeting inclusion criteria in 2008-2009, 17.3% (n = 936) achieved the 3-part ABC goal. In this managed care setting, achievement of the 3-part ABC goal surpassed the proportions reported in previous studies in NHANES data (5.2% in 1988-1994, 7.3% in 1999-2000, 7.0% in 1999-2002, 13.2% in 2003-2004), and 10.1% in Look AHEAD 2001-2004, but fell short of the 22.0% reported in CBEP 2000- 2004. When compared with the 2001-2002 results at ICVA, the proportion of patients achieving the individual A1c goal in 2008-2009 increased by 10.8 percentage points (from 43.2% to 54.0%), 12.6 percentage points for blood pressure (from 29.2% to 41.8%), and 17.1 percentage points for LDL-C (from 49.5% to 66.6%, P < 0.001) for the 3 individual comparisons.
CONCLUSIONS: The proportion of patients achieving each of the 3 goals for A1c, blood pressure, and LDL-C improved significantly in 2008-2009 compared with the 2001-2002 assessment in this medical center, following implementation of yearly clinical reminders for diabetes care, enhanced patient education, and other program changes that included home-based telephone monitoring with diabetes case management for some patients. Achievement of the 3-part ABC goal in 2008-2009 (17.3%) surpassed 5 assessments reported in the literature but was lower than the CBEP (2000- 2004) performance (22.0%).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21534641     DOI: 10.18553/jmcp.2011.17.4.304

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


  23 in total

Review 1.  Quality indicators and performance measures in diabetes care.

Authors:  David C Aron
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

Review 2.  Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?

Authors:  Timothy J Shoemaker; Tatsuyoshi Kono; Cary N Mariash; Carmella Evans-Molina
Journal:  Endocr Pract       Date:  2012 Nov-Dec       Impact factor: 3.443

3.  Blood Pressure and Blood Glucose Control and Associated Factors Among Adults with Hypertension at Three Public Hospitals in Southern Ethiopia.

Authors:  Mende Mensa Sorato; Majid Davari; Abbas Kebriaeezadeh; Nizal Sarrafzadegan; Tamiru Shibru
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-04-11

4.  Achieving Coordinated Care for Patients With Complex Cases of Cancer: A Multiteam System Approach.

Authors:  Simon J Craddock Lee; Mark A Clark; John V Cox; Burton M Needles; Carole Seigel; Bijal A Balasubramanian
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

5.  Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems.

Authors:  Emily B Schroeder; Rebecca Hanratty; Brenda L Beaty; Elizabeth A Bayliss; Edward P Havranek; John F Steiner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-07-31

6.  A randomized comparison of online- and telephone-based care management with internet training alone in adult patients with poorly controlled type 2 diabetes.

Authors:  Graham T McMahon; Stephanie J Fonda; Helen E Gomes; George Alexis; Paul R Conlin
Journal:  Diabetes Technol Ther       Date:  2012-09-06       Impact factor: 6.118

7.  An exploration of the potential reach of smartphones in diabetes.

Authors:  Katherine S Blondon; Paul L Hebert; James D Ralston
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

8.  Stimulatory Effect of Balanced Deep-Sea Water Containing Chitosan Oligosaccharides on Glucose Uptake in C2C12 Myotubes.

Authors:  Byung Geun Ha; Jung-Eun Park; Yun Hee Shon
Journal:  Mar Biotechnol (NY)       Date:  2016-05-23       Impact factor: 3.619

9.  Predictors for achieving target glycemic control in Japanese patients with type 2 diabetes after initiation of basal supported oral therapy using insulin glargine: sub-analysis of the ALOHA2 study, drug use surveillance in Japan.

Authors:  Yukio Ikeda; Shoko Tsukube; Takashi Kadowaki; Masato Odawara
Journal:  Diabetol Int       Date:  2015-10-05

10.  Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.

Authors:  Ben S Gerber; Lauren Rapacki; Amparo Castillo; Jessica Tilton; Daniel R Touchette; Dan Mihailescu; Michael L Berbaum; Lisa K Sharp
Journal:  BMC Public Health       Date:  2012-10-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.